US Patent Issued to Immatics Biotechnologies on May 13 for "Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers" (German Inventors)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,254, issued on May 13, was assigned to Immatics Biotechnologies GmbH (Tubingen, Germany).

"Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers" was invented by Andrea Mahr (Tuebingen, Germany), Toni Weinschenk (Tuebingen, Germany), Colette Song (Tuebingen, Germany), Oliver Schoor (Tuebingen, Germany), Jens Fritsche (Tuebingen, Germany) and Harpreet Singh (Tuebingen, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherap...